Small Cap Feast
Small Cap Feast – 19 November 2020
Dish of the Day:
No Joiners Today
No Joiners Today
Off the Menu:
No Leavers Today
No Leavers Today
What’s Cooking in the IPO Kitchen?
PensionBee the online pension provider , reported to be considering an IPO on the LSE in the Times at a valuation that could exceed £300m.
DrMartens, the iconic shoe brand is preparing for a £1bn initial IPO next year according to Sky News.
Conduit Holdings is a newly established reinsurance underwriting business focusing on producing strong risk adjusted returns from a diversified and focused business plan. The business has been formed to capitalise on what the Company’s founders, Neil Eckert and Trevor Carvey believe to be an exceptional market opportunity. Raising $1.1bn. Due December
Helium One Global to join AIM. The Company, through its Tanzanian subsidiaries, holds a 100% interest in 18 licences (the Priority Licences) covering an area of 4,512km2 with an Unrisked Prospective Helium Resource (2U) of 138Bcf (SRK 2019). The Company has spent US$8.25m on exploration, assessment and related activity to date and is now drill ready. Capital to be raised on Admission: £6million. Anticipated market capitalisation on Admission £14.1 million (at the issue price of 2.84p). Due 4 Dec
Downing Renewables & Infrastructure Trust intends to raise up to £200 million to target the acquisition of a diversified portfolio of renewable energy and other infrastructure assets and list on the Official List of the Financial Conduct Authority and Main Market of the London Stock Exchange . Due by mid December
Ecofin U.S. Renewables Infrastructure Trust. Initial public offering of up to us$250 million to invest in a diversified portfolio of mixed US renewable energy assets with an attractive long-term income stream. Main market premium. Due 14 Dec
VH Global Sustainable Energy Opportunities plc, a closed-ended investment company focused on making sustainable energy infrastructure investments, today announces intends to launch an initial public offering of shares on the Official List (Premium) of the Financial Conduct Authority and Main Market of the London Stock Exchange. Due by Early Feb 2021
Tirupati Graphite, the fully-integrated, cash generative, specialist graphite and graphene producer with operations in Madagascar and India, announced its potential intention to undertake an initial public offering on the LSE (standard listing). Due December
Schroders British Opportunities Trust is seeking to raise up to £250 million on the premium segment of the Official List . The Company believes that there is a once in a generation opportunity to invest equity capital into high quality, high growth UK Companies in the c. £50 million to £2 billion equity value range with sustainable business models at attractive valuations. Due 1 December.
Bytes Technology Group one of the UK’s leading software, security and cloud services specialists, announces that the Company intends to publish a Registration Document and is considering proceeding with an initial public offering (Main Mkt Prem). FY20 gross profit of £79.2m (+24.5% against FY19) and adjusted operating profit of £31.7m (+53.9% against FY19). Highly cash generative with FY20 cash conversion of 125.9% (FY19 cash conversion 139.7%). Bytes due on or around 17 December 2020.
Mailbox REIT PLC , a newly formed single asset company which owns the Mailbox , a large prime office-led mixed use property in Birmingham which has been independently valued at £179m, announced its intention to raise up to £62.5m. MailBox REIT will apply for the Ordinary Shares be admitted to trading on the IPSX Prime segment of International Property Securities Exchange (IPSX ). Due November.
Umuthi Healthcare Solutions Plc, the technology led healthcare business focused on the distribution of pharmaceuticals and the provision of medical facilities in remote areas, seeking admission to the Standard Listing segment of the Official List. Timing tbc
Kibo Energy PLC, the multi-asset Africa focused energy Company, is seeking admission for its 100% owned UK subsidiary Sloane Developments Ltd , which will be renamed Mast Energy Developments PLC (MED), to the Standard List of the London Stock Exchange plc. The MED business strategy is to acquire and develop a portfolio of flexible small-scale power generation assets, exploiting a growth niche market in the UK for Reserve Power generation to balance out the national grid at critical times. Targeted for Q4 2020.
BION 2.7p £11.6m (BION.L)
The environmental engineering, wastewater treatment and renewable energy solutions company, announces that it has today signed a number of non-binding Memorandums of Understanding with three parties, with complementary expertise and resources in the biogas industry in Malaysia, to work together to advance their joint interests. The parties will now seek to enter formal partnerships, which would enable a significant strengthening and expansion of the Company’s biogas and broader waste-to-energy activities. The parties are:
- Green Lagoon Technology Sdn Bhd, a developer of biogas power plants for customers and those that are wholly-owned, with a specialisation in in-ground bioreactor systems. GLT currently has four grid-connected biogas power plants generating a total of 6MW.
- LIPP Engineering Sdn Bhd, an engineering, procurement and construction company focused on generating renewable energy from various biomass or waste sources utilising its German-developed technology. In addition, through a subsidiary company, LIPP has strong manufacturing capabilities enabling it to produce advanced equipment and machinery.
- SIRIM Tech Venture Sdn Bhd, a government organisation established to promote technological advancement and adoption to drive industrial efficiency and development in Malaysia.
Mirada 85p £7.6m (MIRA.L)
The provider of integrated software solutions for digital TV operators and broadcasters, announces the integration of Disney+ into its Iris multiscreen product, and its successful deployment across Televisa’s izzi pay TV platform.
This integration is the result of a collaboration between izzi, Disney and Mirada, enabling the arrival of Disney+ in Mexico as part of the integrated services offered by izzi to their subscribers. Customers of izzi’s recently launched izzitv smart service can now access Disney+ directly through izzi’s TV platform and without the need for a separate subscription, and enjoy the diverse Disney+ catalogue which includes all Disney, Pixar, Marvel, Star Wars, National Geographic and original Disney+ content. Direct access to Disney+ is available through izzi’s home screen on Android TV-based set-top boxes and other devices such as iOS/Android smartphones and tablets, or laptops.
Science in Sport 31p £42m (SIS.L)
The premium performance nutrition company serving elite athletes, sports enthusiasts and the gym lifestyle community, announced its first major launch of an environment-friendly pack.
The Company has invested in packaging technology and plant to convert the bulk of its protein powder range into recyclable pouch packaging, this being a first for the sports nutrition industry globally.
The PhD Nutrition pouch range will move to recyclable material, commencing with the Diet Whey range at the start of December, with a full range change completed in early 2021. In the last 12 months, PhD Nutrition has filled 700,000 pouches which have ultimately gone to landfill.
NetScientific 51p £7.6m (NSCI.L)
The life sciences, technology investment and commercialisation company, announces that its portfolio company ProAxsis Limited, today announced that it has appointed DiaPharma Group Inc. as the exclusive distributor of its portfolio of respiratory research assays for the key North America region.
Based in Ohio, DiaPharma has specialised in the commercialisation of products within the research and diagnostic fields in the United States and Canada since it was founded in 1997. This partnership agreement provides them with exclusive access to ProAxsis’ activity-based immunoassay kits for the quantification of the active forms of neutrophil elastase, proteinase 3 and cathepsin G.
B.P Marsh 247p £92.4m (BPM.L)
The specialist investor in early stage financial services businesses, announced that one of its investments, Lilley Plummer Risks Limited, the nascent specialist Lloyd’s broker, is on course to produce brokerage fees in excess of US $2m in its first year of trading, exceeding its strategic goals more quickly than originally planned.
Open Orphan 24.25p £161.98m (ORPH.L)
The specialist CRO pharmaceutical services company which is the world leader in the testing of vaccines and antivirals using human challenge clinical trials announced that its subsidiary hVIVO has been selected to lead a consortium, on behalf of HIC-Vac, an international network of researchers who are developing human infection challenge (HIC) studies to accelerate the development of vaccines against pathogens, and the Wellcome Trust, to generate regulatory style guidelines on the manufacture of human challenge agents for subsequent use in controlled human infection studies (CHIM).
URU Metals 235p £3.5m (URU.L)
URU has appointed Mr. Justin Cochrane to the Company’s Advisory Board.
Mr. Cochrane is President and CEO of Conic Metals Corp., a global nickel and cobalt royalty and streaming company. He has 20 years of royalty and stream financing, M&A, and corporate finance experience. Prior to Conic Metals, he served as President & COO of Cobalt 27 Capital Corp. and before that as Executive Vice President and Head of Corporate Development for Sandstorm Gold Ltd. Mr. Cochrane’s expertise is in the structuring, negotiation, execution and funding of royalty and stream financing contracts around the world, across dozens of projects, totalling over $2 billion.
Inspecs Group 218p £154.4m (SPEC.L)
Inspecs Group plc, a leading designer, manufacturer and distributor of eyewear frames, today announces a proposed placing at 210 to raise £64 million to part fund the acquisition of Eschenbach Holding GmbH . Eschenbach is a leading, global, eyewear supplier headquartered in Nuremberg, Germany. It has two divisions, one focused on designing and distributing glasses frames and one on designing, manufacturing and distributing specialist optics products.
For the financial year ended 31 December 2019 Eschenbach generated audited revenues of €143.3 million (approximately $169.2 million having grown revenue at a compound annual growth rate of 5.9% between 2017 and 2019. EBITDA (excluding leasing costs) was €10.3 million (approximately $12.2 million) in 2019 and the business was cash generative.
The Acquisition is expected to be earnings accretive for Inspecs in the financial year ending 31 December 2021.
Panthera Resources 9.5p £8.1m (PAT.L)
The diversified gold exploration and development company with assets in West Africa and India, has identified two new gold exploration targets at its Bido Project, located in the prolific Boromo greenstone belt within the Birimian terrain of Burkina Faso. The new targets, Tiekouyou Rush and Beredo have been identified as a result of the recent site visit to coordinate the planned geochemical gold in soil survey, due to commence later this month.
- A large new target of very recent artisanal mining activity identified at Tiekouyou Rush
- Artisanal activity already covers an area of approximately 170m x 170m
- Artisanal mining activity targeting both quartz veins and altered dolerite
- Tiekouyou Rush is in the area proposed for a gold in soil survey commencing today
- The survey will assist in defining the extent of this newly identified target
In addition, during the recent site visit, an area of quartz veining was identified in the northeast of the planned survey area (Beredo Target). The zone appears to extend in a north-northeast direction trending from the area of proposed soil sampling. A detailed review of historical data in this area towards the Bido Vein is currently underway with an update on the findings to be provided shortly.
WANdisco 460p £241.9m (WAND.L)
The LiveData company, has won a contract with a South African-based financial services group and one of the largest banks in Africa to migrate and manage data from on-premise to AWS.
Following the agreement, the Customer will license WANdisco’s LiveData products to migrate data from its on-premise Hadoop cluster to Amazon Web Services S3. This is the first of a number of planned phases for the Customer to migrate data and maintain an on-going hybrid cloud.
This represents the third contract the Company has secured since launching the LiveData product on AWS in September 2020, highlighting the growing momentum and acknowledgement of its LiveData capabilities.
0203 764 2344
*A corporate client of Hybridan LLP
This document, which does not constitute research, has been issued by Hybridan LLP for information purposes only and should not be construed in any circumstances as an offer to sell or solicitation of any offer to buy any security or other financial instrument, nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to any such action. This document has no regard for the specific investment objectives, financial situation or needs of any specific person or entity and is not a personal recommendation to any such person or entity. Recipients should reach an individual investment decision, based upon their respective financial objectives and financial resources and, if any doubt, should seek advice from an investment advisor.
The information contained in this document is based on materials and sources that are believed to be reliable; however, such information has not been independently verified and therefore it is not possible to confirm such information as being accurate. This document is not intended to be a complete statement or summary of any securities, markets, reports or developments referred to herein. No representation or warranty, either express or implied, is made or accepted by Hybridan LLP, its members, officers, employees, agents or associated undertakings in relation to the accuracy, completeness or reliability of the information contained in this document, nor should it be relied upon as such.
The content of this document includes market commentary and other information which we have prepared in relation to the company referred to in this document, which is our broking client. The provision of this document to you constitutes a minor non-monetary benefit which is capable of enhancing the quality of service provided by Hybridan LLP and which is of a scale and nature which could not be judged to impair the duty of Hybridan LLP to act in the best interest of its client falling within article 24(7)(b) of Regulation 600/2014/EU (MIFID II Regulation).
Any and all opinions expressed are current as of the date appearing on this face of this document only. Any and all opinions expressed are subject to change without notice and Hybridan LLP is under no obligation to update the information contained herein. To the fullest extent permitted by law, none of Hybridan LLP, its members, officers, employees, agents or associated undertakings shall have any liability whatsoever for any direct or indirect or consequential loss or damage (including lost profits) arising in any way from use of all or any part of the information in this document.
This document should not be relied upon as being an independent or impartial view of the subject matter and, for the avoidance of doubt, constitutes non-independent research (as such term is defined in the Financial Conduct Authority’s Conduct of Business Sourcebook to reflect the requirements of the MIFID II Regulation and Directive 2014/65/EU (known as MIFID II)). The individuals who prepared this document may be interested in shares in the company concerned and/or other companies within its sector, may be involved in providing other financial services to the company or companies referenced in this document or to other companies who might be said to be competitors of the company or companies referenced in this document. As a result both Hybridan LLP and the individual members, officers and/or employees who prepared this document may have responsibilities that conflict with the interests of the persons who receive this document. Hybridan LLP and/or connected persons may, from time to time, have positions in, make a market in and/or effect transactions in any investment or related investment mentioned herein and may provide financial services to the issuers of such investments.
In the United Kingdom, this document is directed at and is for distribution only to persons who (i) fall within article 19(5) (persons who have professional experience in matters relating to investments) or article 49(2) (a) to (d) (high net worth companies, unincorporated associations, etc.) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (SI 2005/1529) (as amended) or (ii) persons who are each a professional client or eligible counterparty (as those terms are defined in the Financial Conduct Authority’s Conduct of Business Sourcebook) of Hybridan LLP (all such persons referred to in (i) and (ii) together being referred to as relevant persons). This document must not be acted on or relied up on by persons who are not relevant persons. For the purposes of clarity, this document is not intended for and should not be relied upon by any person who would be classified as a retail client under the Financial Conduct Authority’s Conduct of Business Sourcebook.
Neither this document, nor any copy of part thereof may be distributed in any other jurisdictions where its distribution may be restricted by law and persons into whose possession this document comes should inform themselves about, and observe, any such restrictions. Distribution of this report in any such other jurisdictions may constitute a violation of territorial and/or extra-territorial securities laws, whether in the United Kingdom, the United States or any other jurisdiction in any part of the world.
Where possible this document is made available to all relevant recipients at the same time. Dissemination of research by Hybridan LLP is monitored to ensure that it is only provided to relevant persons. Research prepared by Hybridan LLP is not intended to be received and/or used by any person who is a retail client.
Hybridan LLP and/or its associated undertakings may from time-to-time provide investment advice or other services to, or solicit such business from, any of the companies referred to in this document. Accordingly, information may be available to Hybridan LLP that is not reflected in this material and Hybridan LLP may have acted upon or used the information prior to or immediately following its publication. In addition, Hybridan LLP, the members, officers and/or employees thereof and/or any connected persons may have an interest in the securities, warrants, futures, options, derivatives or other financial instrument of any of the companies referred to in this document and may from time-to-time add or dispose of such interests.
This document may not be copied, redistributed, resent, forwarded, disclosed or duplicated in any form or by any means, whether in whole or in part other than with the prior written consent of Hybridan LLP.
MIFID II status of Hybridan LLP research
The cost of production of our corporate research is met by retainers from our corporate broking clients. In addition, from time to time we issue further communications as market commentary (such as our daily newsletter, Small Cap Breakfast), which we consider to constitute a minor non-monetary benefit which is capable of enhancing the quality of service provided by Hybridan LLP and which is of a scale and nature which could not be judged to impair the duty of Hybridan LLP to act in the best interest of its client falling within article 24(7)(b) of the MIFID II Regulation.
Hybridan LLP is a limited liability partnership registered in England and Wales, registered number OC325178, and is authorised and regulated by the Financial Conduct Authority and is a member of the London Stock Exchange. Any reference to a partner in relation to Hybridan LLP is to a member of Hybridan LLP or an employee with equivalent standing and qualifications. A list of the members of Hybridan LLP is available for inspection at the registered office, 2 Jardine House, The Harrovian Business Village, Bessborough Road, Harrow, Middlesex HA1 3EX.
If you would like to unsubscribe, please email firstname.lastname@example.org with “unsubscribe me”.